REGENXBIO Inc. (RGNX): Price and Financial Metrics
RGNX Price/Volume Stats
| Current price | $6.29 | 52-week high | $19.88 |
| Prev. close | $6.67 | 52-week low | $5.62 |
| Day low | $6.26 | Volume | 1,087,600 |
| Day high | $6.55 | Avg. volume | 972,945 |
| 50-day MA | $7.32 | Dividend yield | N/A |
| 200-day MA | $9.75 | Market Cap | 315.04M |
RGNX Stock Price Chart Interactive Chart >
REGENXBIO Inc. (RGNX) Company Bio
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.
RGNX Price Returns
| 1-mo | -0.79% |
| 3-mo | -23.20% |
| 6-mo | -34.21% |
| 1-year | -67.19% |
| 3-year | -80.95% |
| 5-year | -78.94% |
| YTD | -18.63% |
| 2024 | -56.94% |
| 2023 | -20.86% |
| 2022 | -30.64% |
| 2021 | -27.91% |
| 2020 | 10.72% |
Continue Researching RGNX
Want to do more research on REGENXBIO Inc's stock and its price? Try the links below:REGENXBIO Inc (RGNX) Stock Price | Nasdaq
REGENXBIO Inc (RGNX) Stock Quote, History and News - Yahoo Finance
REGENXBIO Inc (RGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...